BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2015
View Archived Issues
Cempra reports topline phase III data for intravenous solithromycin
Read More
Novel polymyxin derivatives show antibacterial activity
Read More
Sunshine Lake Pharma reports anti-HBV agents
Read More
Radiolabeled G-02113 may be useful for in vivo imaging of sst receptor-expressing tumors
Read More
PharmaCyte outlines plans for upcoming pancreatic cancer trial of Cell-in-a-Box + ifosfamide
Read More
Medifocus in license agreement with Duke for heat-activated and tumor-targeted immunotherapy
Read More
Alnylam describes a more potent RNAi agent targeting transthyretin for treating amyloidosis
Read More
Profiling of novel inhibitors of bacterial topoisomerases
Read More
Avalanche Biotechnologies reports 1-year follow up from phase I trial of rAAV.sFLT-1
Read More
Agios Pharmaceuticals provides pipeline update
Read More
Kowa files for approval of pemafibrate in Japan
Read More
Genocea reports topline results from phase IIa trial of universal Pneumococcal vaccine
Read More
Addyi launched in the U.S. for generalized hypoactive sexual desire disorder
Read More
Allergan completes acquisition of AqueSys
Read More
Novel JAK3 inhibitor shows promise for Th2-driven diseases
Read More
European Commission approves isavuconazole for invasive aspergillosis and mucormycosis
Read More
Roche discloses CB2 inverse agonists
Read More
Syros Pharmaceuticals patents CDK7 inhibitors
Read More
Instytut Farmaceutyczny reports antineoplastic agents
Read More
Calitor Sciences presents protein kinase inhibitors
Read More
Orion presents TRPA1 antagonists
Read More
Inotuzumab ozogamicin receives FDA breakthrough therapy designation for ALL
Read More
CFTR amplifiers enhance the effect of CFTR modulators
Read More
La Jolla Pharmaceutical starts phase I trial of hepcidin formulation LJPC-401
Read More
Avedro resubmits NDA for corneal cross-linking system
Read More
GenKyoTex's GKT-137831 granted U.S. orphan status for systemic sclerosis
Read More